Literature DB >> 166843

Cyclic amp concentration and enzyme activities of cerebrospinal fluid in patients with epilepsy or central nervous system damage.

V V Myllylä, E R Heikkinen, H Vapaatalo, E Hokkanen.   

Abstract

Cyclic adenosine-3',5'-monophosphate (cAMP) concentration in cerebrospinal fluid (CSF) was measured by the protein binding method of Gilman from 62 neurological patients, 46 of them were epileptics and 16 with a central nervous system (CNS) damage. In epileptic patients the CSF concentration of cAMP was significantly elevated (p smaller than 0.02) for 3 days after an attack when compared with those free from attacks for at least 2 weeks. The causality relationship between the rise of cAMP in CSF and an epileptic discharge is discussed. In patient with an active or rapidly progressing CNS damage the cAMP levels in the CSF were significantly higher (p smaller than 0.001) than in those with an old CNS damage. Also some enzyme activities in CSF were measured but no uniform alterations could be found. In damaging processes of the CNS, the cAMP values in the CSF seem to correlate to the activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166843     DOI: 10.1159/000114668

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.

Authors:  E R Heikkinen; S Similä; V V Myllylä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975-11-13

3.  Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.

Authors:  H Cramer; J Kohler; G Oepen; G Schomburg; E Schröter
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

5.  CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction.

Authors:  T Büttner; C R Hornig; O Busse; W Dorndorf
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

6.  Decreased cerebrospinal fluid cyclic adenosine 3',5'-monophosphate in bacterial meningitis.

Authors:  S Weitzman; L B Palmer; S A Berger
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

7.  Role of central beta-adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats.

Authors:  W J Louis; J Papanicolaou; R J Summers; F J Vajda
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

8.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Cyclic adenosine 3',5' monophosphate in cerebrospinal fluid of multiple sclerosis patients.

Authors:  E Maida; W Kristoferitsch
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

10.  Studies on cyclic AMP in different compartments of cerebrospinal fluid.

Authors:  D Tsang; S Lal; T L Sourkes; R M Ford; A Aronoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.